{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:22:45Z","timestamp":1785892965720,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:00:00Z","timestamp":1471305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00259-016-3465-7","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T23:02:39Z","timestamp":1471302159000},"page":"2413-2422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal"],"prefix":"10.1007","volume":"43","author":[{"given":"Helga","family":"Castagnoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Ferrantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Coppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Passeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sciagr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"key":"3465_CR1","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","volume":"124","author":"BJ Gersh","year":"2011","unstructured":"Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF\/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: executive Summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2761\u201396.","journal-title":"Circulation"},{"key":"3465_CR2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu199","volume":"35","author":"PM Elliott","year":"2014","unstructured":"Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733\u201379.","journal-title":"Eur Heart J"},{"key":"3465_CR3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","volume":"64","author":"BJ Maron","year":"2014","unstructured":"Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol. 2014;64:83\u201399.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa025050","volume":"349","author":"F Cecchi","year":"2003","unstructured":"Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027\u201335.","journal-title":"N Engl J Med"},{"key":"3465_CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2005.10.050","volume":"47","author":"I Olivotto","year":"2006","unstructured":"Olivotto I, Cecchi F, Gistri R, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2006;47:1043\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0735-1097(91)90869-B","volume":"17","author":"P Camici","year":"1991","unstructured":"Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and non hypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol. 1991;17:879\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65:1249\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","volume":"65","author":"BJ Maron","year":"2015","unstructured":"Maron BJ, Rowin EJ, Casey SA, et al. Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies. J Am Coll Cardiol. 2015;65:1915\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/heartjnl-2014-306387","volume":"101","author":"LR Lopes","year":"2015","unstructured":"Lopes LR, Syrris P, Guttmann OP, et al. Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. Heart. 2015;101:294\u2013301.","journal-title":"Heart"},{"key":"3465_CR10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2967\/jnumed.107.050138","volume":"49","author":"B Sotgia","year":"2008","unstructured":"Sotgia B, Sciagr\u00e0 R, Olivotto I, et al. Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med. 2008;49:1090\u20136.","journal-title":"J Nucl Med"},{"key":"3465_CR11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12350-008-9005-5","volume":"16","author":"R Sciagr\u00e0","year":"2009","unstructured":"Sciagr\u00e0 R, Sotgia B, Olivotto I, et al. Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2009;16:92\u20136.","journal-title":"J Nucl Cardiol"},{"key":"3465_CR12","first-page":"948653","volume":"2012","author":"R Sciagr\u00e0","year":"2012","unstructured":"Sciagr\u00e0 R. Quantitative cardiac positron emission tomography: the time is coming! Scientifica (Cairo). 2012;2012:948653.","journal-title":"Scientifica (Cairo)"},{"key":"3465_CR13","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s00259-016-3317-5","volume":"43","author":"R Sciagr\u00e0","year":"2016","unstructured":"Sciagr\u00e0 R, Passeri A, Bucerius J, et al. Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging. 2016;43:1530\u201345.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3465_CR14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jacc.2011.05.018","volume":"58","author":"I Olivotto","year":"2011","unstructured":"Olivotto I, Girolami F, Sciagr\u00e0 R, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol. 2011;58:839\u201348.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","volume":"105","author":"MD Cerqueira","year":"2002","unstructured":"Cerqueira MD, Weissman NJ, Dilsizian V, et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation. 2002;105:539\u201342.","journal-title":"Circulation"},{"key":"3465_CR16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1071-3581(96)90059-8","volume":"3","author":"TR DeGrado","year":"1996","unstructured":"DeGrado TR, Hanson MW, Turkington TG, et al. Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography. J Nucl Cardiol. 1996;3:494\u2013507.","journal-title":"J Nucl Cardiol"},{"key":"3465_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCULATIONAHA.109.878579","volume":"121","author":"BJ Maron","year":"2010","unstructured":"Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010;121:445\u201356.","journal-title":"Circulation"},{"key":"3465_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","volume":"5","author":"I Olivotto","year":"2012","unstructured":"Olivotto I, Cecchi F, Poggesi C, Yacoub MH. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail. 2012;5:535\u201346.","journal-title":"Circ Heart Fail"},{"key":"3465_CR19","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.112.123174","volume":"126","author":"BJ Maron","year":"2012","unstructured":"Maron BJ, Braunwald E. Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease. Circulation. 2012;126:1640\u20134.","journal-title":"Circulation"},{"key":"3465_CR20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2012-303271","volume":"99","author":"C O\u2019Mahony","year":"2013","unstructured":"O\u2019Mahony C, Tome-Esteban M, Lambiase PD, et al. A validation study of the 2003 American College of Cardiology\/European Society of Cardiology and 2011 American College of Cardiology Foundation\/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy. Heart. 2013;99:534\u201341.","journal-title":"Heart"},{"key":"3465_CR21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830\u201340.","journal-title":"N Engl J Med"},{"key":"3465_CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12265-009-9142-5","volume":"2","author":"F Cecchi","year":"2009","unstructured":"Cecchi F, Sgalambro A, Baldi M, et al. Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2009;2:452\u201361.","journal-title":"J Cardiovasc Transl Res"},{"key":"3465_CR23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jacc.2009.04.072","volume":"54","author":"MS Maron","year":"2009","unstructured":"Maron MS, Olivotto I, Maron BJ, et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54:866\u201375.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR24","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.106.657023","volume":"115","author":"SE Petersen","year":"2007","unstructured":"Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation. 2007;115:2418\u201325.","journal-title":"Circulation"},{"key":"3465_CR25","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","volume":"33","author":"R Spoladore","year":"2012","unstructured":"Spoladore R, Maron MS, D\u2019Amato R, Camici PG, Olivotto I. Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J. 2012;33:1724\u201333.","journal-title":"Eur Heart J"},{"key":"3465_CR26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/HJH.0b013e328340a08e","volume":"29","author":"D Neglia","year":"2011","unstructured":"Neglia D, Fommei E, Varela-Carver A, et al. Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. J Hypertens. 2011;29:364\u201372.","journal-title":"J Hypertens"},{"key":"3465_CR27","first-page":"222","volume":"2013","author":"R Coppini","year":"2013","unstructured":"Coppini R, Ferrantini C, Mazzoni L, et al. Regulation of intracellular Na(+) in health and disease: pathophysiological mechanisms and implications for treatment. Glob Cardiol Sci Pract. 2013;2013:222\u201342.","journal-title":"Glob Cardiol Sci Pract"},{"key":"3465_CR28","first-page":"243","volume":"2013","author":"I Olivotto","year":"2013","unstructured":"Olivotto I, Tomberli B, Spoladore R, Mugelli A, Cecchi F, Camici PG. Hypertrophic cardiomyopathy: The need for randomized trials. Glob Cardiol Sci Pract. 2013;2013:243\u20138.","journal-title":"Glob Cardiol Sci Pract"},{"key":"3465_CR29","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.01.023","volume":"67","author":"MS Maron","year":"2016","unstructured":"Maron MS, Rowin EJ, Olivotto I, et al. Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2016;67:1399\u2013409.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1148\/radiol.14131626","volume":"273","author":"J Bogaert","year":"2014","unstructured":"Bogaert J, Olivotto I. MR Imaging in hypertrophic cardiomyopathy: from magnet to bedside. Radiology. 2014;273:329\u201348.","journal-title":"Radiology"},{"key":"3465_CR31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(00)04005-8","volume":"357","author":"PM Elliott","year":"2001","unstructured":"Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357:420\u20134.","journal-title":"Lancet"},{"key":"3465_CR32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0735-1097(02)02713-4","volume":"41","author":"I Olivotto","year":"2003","unstructured":"Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;41:315\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"3465_CR33","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","volume":"342","author":"P Spirito","year":"2000","unstructured":"Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778\u201385.","journal-title":"N Engl J Med"},{"key":"3465_CR34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2967\/jnumed.111.095398","volume":"53","author":"PJ Slomka","year":"2012","unstructured":"Slomka PJ, Alexanderson E, J\u00e1come R, et al. Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET\/CT. J Nucl Med. 2012;53:171\u201381.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3465-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-016-3465-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-016-3465-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:46:33Z","timestamp":1498337193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-016-3465-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3465"],"URL":"https:\/\/doi.org\/10.1007\/s00259-016-3465-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]}}}